A study published in JAMA Network Open examined the cognitive function in patients following COVID-19 Infection. The researchers analyzed data from a cohort of COVID-19 patients from April 2020 through May 2021 and investigated rates of cognitive impairment in survivors who were treated in outpatient, emergency department, or inpatient hospital settings. Prior studies were hindered by limited sample sizes and substandard evaluation of cognitive functioning.
Search Results for: COVID
Ticks & Biowarfare Investigation Passes House/Last Chance to Register for LDA Conf. Before Price Increase/COVID Impacts on Lyme Reporting/Monoclonal Antibody COVID Treatment/LDA Doctor Referral Now Open/Valneva Lyme Vaccine
The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment.
NC Department of Health and Human Services has offered information advising how patients can locate services for monoclonal antibodies treatment for COVID-19 infections. The NCDHHS website states, “The Food and […]
Register Now for LDA-Columbia Virtual Conf./New LDA Dr. Referral/Cohen TBD Recovery Center Launch/The State of Lyme Disease/Moderna Vs. Pfizer/Organ-Transplant-Derived Ehrlichiosis/B. Mayonii on Blood Smear/T Cell Exhaustion/COVID in Deer/TBDWG/ABEM
The Lyme Disease Association Inc. and Columbia University Vagelos College of Physicians & Surgeons are jointly providing the 21st annual CME scientific conference, Lyme & Other Tick-Borne Diseases: Research for a Cure, virtually, on October 2, 2021. This conference is designed to meet the high standards for continuing medical education credits for medical & health professionals and researchers.
Findings of a recent study, Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence, show that Moderna’s COVID-19 vaccine appears to have a […]
Lyme, Mental Disorders & Suicide/Breaking News! $8M for Lyme/LDA ’21 Conf./MDH Warning/CPAP, BiPAP Recall/COVID Bias & TBD Diagnosis/Bartonella Research/IPM WG Tick Academy/CLD & Contrast Sensitivity/Submit Study Concepts/Final TBDWG Mtg./RI Lyme
In a study with lead author, Dr. Brian Fallon, using Denmark’s National Patient Registry and Psychiatric Central Research Registry – including all persons living in Denmark from 1994-2016 – the risk of mental disorders and suicides among all diagnosed with Lyme borreliosis was assessed. Those individuals with Lyme borreliosis had higher rates of any mental and affective disorders, and suicide attempts or deaths by suicide compared with those without Lyme.
Harold W. Horowitz, et al., published the research letter, “COVID-19 and the Consequences of Anchoring Bias” in the CDC’s August publication of the monthly journal, Emerging Infectious Diseases. The authors disclose how suspected coronavirus disease in febrile patients can influence healthcare providers’ decisions and may result in misdiagnosing other serious infections with epidemiologic risk.
EM Treatment Guidelines/Need Tick Bite Reporting/Lyme Press Conf./Myocarditis After COVID Vax/Long Haul COVID Treatment Protocol/CDC’s Final 2019 Nos./Columbia Trials Network/CFC Approves LDA as Nat’l Charity/Asian Longhorned Tick/IDSA Retracts Pub
Elizabeth L. Maloney, MD, reviews the US trial evidence on EM rashes, problems of the IDSA recommendations considering that evidence, and provides evidence-based patient-centered strategies for managing patients with EM. “The EM rash is the hallmark finding of early disease,” along with other symptoms. “In light of the physical and financial costs, identifying and promoting highly effective therapeutic interventions for US patients with erythema migrans (EM) rashes that return them to their pre-infection health status should be a priority.”